Peter Adams
|
Securities litigation: defense
|
DeAnna Allen
|
Patents: litigation (full coverage)
|
Michael Attanasio
|
Trade secrets (litigation and non-contentious matters) |
Andrew Barr
|
Transport: aviation and air travel - litigation and regulation |
Michael Basile
|
Telecoms and broadcast: transactions
Telecoms and broadcast: regulatory |
Ben Beerle
|
M&A: middle-market ($500m-999m)
|
Keith Berets
|
Technology transactions
|
Laura Berezin
|
Healthcare: life sciences
|
Max Bernstein
|
Patents: litigation (full coverage) |
Ryan Blair
|
Securities litigation: defense
|
Eric Blanchard
|
Capital markets: equity offerings
|
Barbara Borden
|
Healthcare: life sciences
M&A: middle-market ($500m-999m)
M&A: large deals ($1bn+) |
Matthew Brigham
|
Patents: litigation (full coverage)
Trade secrets (litigation and non-contentious matters)
|
Nicole Brookshire
|
Capital markets: equity offerings |
Matthew Brown
|
Cyber law (including data privacy and data protection) |
Fraser Brown
|
Patents: prosecution (including re-examination and post-grant proceedings) |
Alfred Browne
|
Fintech
|
David Burns
|
Merger control |
Kay Chandler
|
Healthcare: life sciences |
Adam Chase
|
Technology transactions |
Reuben Chen
|
Patents: litigation (full coverage)
|
John Clendenin
|
Private equity funds (including venture capital) |
Kevin Cooper
|
M&A: middle-market ($500m-999m)
|
Jon Cousin
|
Patents: prosecution (including re-examination and post-grant proceedings) |
John Crittenden
|
Trademarks: non-contentious (including prosecution, portfolio management and licensing)
Trademarks: litigation |
John Dado
|
Private equity funds (including venture capital)
|
Jonathan Davies
|
Patents: litigation (full coverage)
|
Joseph Drayton
|
Patents: litigation (full coverage)
Trade secrets (litigation and non-contentious matters)
|
Adam Dinow
|
Venture capital and emerging companies |
Ivor Elrifi
|
Healthcare: life sciences
Patents: prosecution (including re-examination and post-grant proceedings)
|
Parker Erkmann
|
Transport: aviation and air travel - litigation and regulation |
Dean Farmer
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
John Feore
|
Telecoms and broadcast: regulatory |
Patrick Flanagan
|
Commercial lending |
Erin Foley
|
Patents: prosecution (including re-examination and post-grant proceedings) |
Joshua Friedman
|
Employee benefits, executive compensation and retirement plans: transactional |
Koji Fukumura
|
Securities litigation: defense
Healthcare: life sciences |
Eamonn Gardner
|
Patents: litigation (full coverage) |
Stephen Gardner
|
US taxes: contentious
|
Adam Gershenson
|
Trade secrets (litigation and non-contentious matters)
|
Bobby Ghajar
|
Trademarks: non-contentious (including prosecution, portfolio management and licensing)
|
Colleen Gillis
|
Land use/zoning
|
Rick Ginsberg
|
Private equity funds (including venture capital)
|
Andrew Goldstein
|
Corporate investigations and white-collar criminal defense
|
Shane Goudey
|
Private equity funds (including venture capital) |
TJ Graham |
Technology transactions
|
Jon Graves
|
Patents: litigation (full coverage)
|
Jackie Grise
|
Merger control
|
Patrick Gunn
|
General commercial disputes |
Div Gupta
|
Capital markets: equity offerings
|
J.G. Harrington
|
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactions
|
Kathleen Hartnett
|
General commercial disputes
Corporate investigations and white-collar criminal defense |
John Hemann
|
Corporate investigations and white-collar criminal defense |
Kate Hillier
|
Healthcare: life sciences |
Chris Holly
|
Patents: prosecution (including reexamination and post-grant proceedings) |
Tanisha James
|
Merger control |
Eric Jensen
|
Capital markets: equity offerings |
Heidi Keefe
|
Patents: litigation (full coverage)
|
Charlie Kim
|
Capital markets: equity offerings |
Kris Kleiner
|
Cyber law (including data privacy and data protection)
|
Mike Klisch
|
General commercial disputes |
Ken Krisko
|
Healthcare: life sciences |
Sale Kwon
|
Venture capital and emerging companies
|
Matthew Langer
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Samantha LaPine
|
Real estate
|
John Lavoie
|
Real estate
Land use/zoning |
Travis LeBlanc
|
Cyber law (including data privacy and data protection)
Telecoms and broadcast: transactions |
Alexander Lee
|
US taxes: non-contentious |
Randall Lee
|
Corporate investigations and white-collar criminal defense
|
Jamie Leigh
|
M&A: middle-market ($500m-999m)
M&A: large deals ($1bn+) |
Michael Levinson
|
Real estate |
Mike Lincoln
|
Venture capital and emerging companies |
Mark Looney
|
Land use/zoning |
Clint Massengill
|
US taxes: contentious |
Mischi a Marca
|
Commercial lending |
Mika Reiner Mayer
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Lesly McAnelly
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Robert McDowell
|
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactions |
Lowell Mead
|
Patents: litigation (full coverage)
|
Erik Milch
|
Patents: litigation (full coverage)
|
Barbara Mirza
|
Employee benefits, executive compensation and retirement plans: transactional
|
Pat Mitchell
|
Venture capital and emerging companies
|
Howard Morse
|
Merger control |
Phillip Morton
|
Patents: litigation (full coverage)
|
Alessandra Murata
|
Employee benefits, executive compensation and retirement plans: transactional
|
Fred Muto
|
Venture capital and emerging companies |
David Navetta
|
Cyber law (including data privacy and data protection)
|
Stephen Neal
|
Leading trial lawyers
|
William O’Connor
|
Transport: aviation and air travel - litigation and regulation |
Kathleen Pakenham
|
US taxes: contentious |
Dave Peinsipp
|
Capital markets: equity offerings |
Nyron Persaud
|
Employee benefits, executive compensation and retirement plans: transactional |
Adam Pivovar
|
Patents: litigation (full coverage) |
Christian Plaza
|
Healthcare: life sciences |
Marya Postner
|
Healthcare: life sciences
|
Rachel Proffitt
|
Venture capital and emerging companies |
Jason Rademacher
|
Telecoms and broadcast: regulatory
|
Michael Rhodes
|
Cyber law (including data privacy and data protection)
Leading trial lawyers |
Michelle Rhyu
|
Healthcare: life sciences
Trade secrets (litigation and non-contentious matters) |
Christina Roupas
|
Real estate investment trusts
Capital markets: debt offerings
Capital markets: equity offerings
|
Adam Ruttenberg
|
Telecoms and broadcast: transactions
Technology transactions
|
Jason Savich
|
Commercial lending
|
Michelle Schulman
|
Real estate |
William Schwartz
|
Corporate investigations and white-collar criminal defense |
Richard Segal
|
Capital markets: equity offerings |
Ian Shapiro
|
General commercial disputes
Trade secrets (litigation and non-contentious matters)
|
Michael Sheetz
|
Trade secrets (litigation and non-contentious matters) |
Lei Shen
|
Cyber law (including data privacy and data protection) |
Jordan Silber
|
Private equity funds (including venture capital) |
Stephen Smith
|
Patents: litigation (full coverage)
Trade secrets (litigation and non-contentious matters) |
Sanya Sukduang
|
Healthcare: life sciences
Patents: litigation (full coverage) |
Marc Suskin
|
International arbitration |
Scott Talbot
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Mark Tanoury
|
Venture capital and emerging companies
|
Rachel Thorn
|
International arbitration
|
Michael Tollini
|
Commercial lending
|
Steve Tonsfeldt
|
M&A: large deals ($1bn+)
|
Michael Tu
|
Securities litigation: defense
|
Michael Tuscan
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Ryan Vann
|
Labor-management relations |
Erich Veitenheimer
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Mark Weinstein
|
Patents: litigation (full coverage)
|
Peter Werner
|
Venture capital and emerging companies |
Scott Weston
|
Patents: prosecution (including re-examination and post-grant proceedings)
|
Adriana Wirtz
|
US taxes: contentious
|
Amy Wood
|
Employee benefits, executive compensation and retirement plans: transactional |
Aric Wu
|
M&A litigation: defense |